By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix's fourth-quarter revenues fell 23 percent year over year, missing analysts' estimates, the company reported after the close of the market on Wednesday.

For the quarter ended Dec. 31, 2011, the Santa Clara, Calif.-based microarray firm said that it posted $65.1 million in revenues, down from $84.9 million a year ago, and short of Wall Street expectations of $65.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.